Use of diet supplements, synthetic drugs and herbal remedies with immunotropic activity during pregnancy. II. Zingiber officinale Roscoe (Ginger)
Publication date: 2011-01-13
Cent Eur J Immunol 2010;35(4)
KEYWORDS
ABSTRACT
This mini-review summarizes some experimental and clinical data about safety of ginger (Zingiber officinale Roscoe) treatment during pregnancy. Ginger is used in many cultures in the management of nausea and vomiting in pregnancy. There is some evidence from animal and human studies that Ginger is not teratogenic. However, the mutagenicity of ginger extracts is a controversial subject, because they contain mutagenic and anti-mutagenic compounds. Experimental studies in mice and fish revealed immunostimulatory and anti-inflammatory properties of ginger.
Share
RELATED ARTICLE
| eISSN: | 1644-4124 |
| ISSN: | 1426-3912 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
